Cargando…

Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy

The impact of the de-escalation strategy of antiplatelet therapy (APT) on the life expectancy after acute coronary syndromes (ACS) and percutaneous coronary intervention (PCI) requires an assessment in real clinical practice. Into the Russian multicentral observational trial (ORACLE II ClinicalTrial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brazhnik, Victoria A., Minushkina, Larisa O., Boeva, Olga I., Khasanov, Niyaz R., Kosmacheva, Elena D., Chichkova, Marina A., Zateyshchikov, Dmitry A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068298/ https://www.ncbi.nlm.nih.gov/pubmed/33917922 http://dx.doi.org/10.3390/jcm10081572

Ejemplares similares

Stratifications and foliations in phase portraits of gene network models
por: Golubyatnikov, V.P., et al.
Publicado: (2022)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2021)

Correction to: D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
por: James, Stefan
Publicado: (2013)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Variability of Antithrombotic Dosing Among Veterans Presenting With Acute Coronary Syndrome
por: Plomondon, Mary E., et al.
Publicado: (2015)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
por: George, Sudhakar, et al.
Publicado: (2019)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy
por: Baturina, Olga, et al.
Publicado: (2023)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
por: Kwon, Osung, et al.
Publicado: (2022)

Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study
por: Knight, Stacey, et al.
Publicado: (2015)

Choice of antithrombotics in acute coronary syndrome – A balance of efficacy versus safety
por: Kaul, Upendra, et al.
Publicado: (2016)

Hypertrophic Cardiomyopathy in Underrepresented Populations: Clinical and Genetic Landscape Based on a Russian Single-Center Cohort Study
por: Chumakova, Olga S., et al.
Publicado: (2023)

Risk Stratification of Patients with Acute Coronary Syndrome
por: Bauer, Dávid, et al.
Publicado: (2021)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
por: Numasawa, Yohei, et al.
Publicado: (2020)

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation
por: Kany, Shinwan, et al.
Publicado: (2021)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007)

Role of biomarkers in risk stratification of acute coronary syndrome
por: Nagesh, C.M., et al.
Publicado: (2010)

Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
por: Baulina, Natalia, et al.
Publicado: (2022)

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome
por: Correa, Simon, et al.
Publicado: (2018)

Optimal Oral Antithrombotic Regimes for Patients with Acute Coronary Syndrome: A Network Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2014)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome
por: Mischie, Alexandru Nicolae, et al.
Publicado: (2017)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options
por: Chan Pin Yin, D. R. P. P., et al.
Publicado: (2021)

Chinese expert consensus on antithrombotic management of high‐risk elderly patients with chronic coronary syndrome
por: Zhang, Cuntai, et al.
Publicado: (2023)

Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice
por: Yan, Yan, et al.
Publicado: (2017)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Comparing an Unstructured Risk Stratification to Published Guidelines in Acute Coronary Syndromes
por: Beck, Ann-Jean CC., et al.
Publicado: (2015)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_er8ok5pb4o4h15tmuri6sps5vr